Polaris Pharmaceuticals Email Format
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Polaris Pharmaceuticals is a privately held, multinational biopharmaceutical company focused on the research and development of protein drugs to treat cancer and other human diseases. Based in San Diego, California, the company operates at 6370 Nancy Ridge Drive, Suite 106, San Diego 92121, United States, and employs 11 to 50 people. Its lead program, ADI-PEG 20, is in advanced clinical development for hepatocellular carcinoma and metastatic melanoma. Polaris collaborates with EnzymeRx on the development of Uricase-PEG 20 for gout, tumor lysis syndrome, and other hyperuricemia-related conditions. In addition to biotherapeutics, the company conducts research into other biotherapeutic agents and maintains a small-molecule drug program that uses structure-based design to target cancer-related proteins.